Glyxambi Tablets combine Empagliflozin and Linagliptin to help manage blood sugar levels in adults with type 2 diabetes. This effective combination supports your diabetes care plan.
USD $36.95
Glyxambi Tablets are an effective solution for managing type 2 diabetes, combining two powerful medications to improve blood sugar control.
Glyxambi Tablets combine empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. This dual-action formula helps lower blood sugar levels by reducing glucose reabsorption in the kidneys and increasing insulin release in response to meals. Glyxambi is designed for adults with type 2 diabetes to enhance glycemic control alongside a balanced diet and exercise regimen.
| Active Ingredients | Empagliflozin, Linagliptin |
|---|---|
| Formulation | Oral Tablets |
| Intended Use | Type 2 Diabetes Management |
Take Glyxambi Tablets once daily, with or without food, as directed by your healthcare provider. It's important to follow your doctor's instructions and maintain a healthy diet and exercise routine for optimal results. Store the tablets in a cool, dry place away from direct sunlight.
Glyxambi is used to improve blood sugar control in adults with type 2 diabetes.
Take one tablet daily, with or without food, as prescribed by your healthcare provider.
Yes, Glyxambi can be used alongside other diabetes medications, but always consult your doctor before combining treatments.
Common side effects may include urinary tract infections, stuffy or runny nose, and sore throat. Contact your healthcare provider if you experience severe side effects.
No, Glyxambi is not intended for use in patients with type 1 diabetes.
If you are pregnant or planning to become pregnant, consult your doctor before taking Glyxambi.
Glyxambi may impact kidney function. Regular monitoring by your healthcare provider is recommended.
Store in a cool, dry place away from direct sunlight and out of reach of children.
Health Guides